Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission

AIDS. 2001 May 25;15(8):1074-5. doi: 10.1097/00002030-200105250-00023.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Cross-Sectional Studies
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control
  • HIV Infections / transmission
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Lactic Acid / blood*
  • Lamivudine / adverse effects
  • Lamivudine / therapeutic use
  • Male
  • Perinatal Care
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Prenatal Care
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Stavudine / adverse effects
  • Stavudine / therapeutic use
  • Zidovudine / adverse effects
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Lactic Acid
  • Zidovudine
  • Stavudine